Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Testa

Showing results (361-370 of 588) with videos related to

Pageof 59
Sort By:
Leukemia|November 1, 1992
The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemiaE J Lee, J Yang, R D Leavitt, et al.
Diabetes, Nutrition & Metabolism|April 27, 2000
A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patientsR Testa, A R Bonfigli, C Sirolla, et al.
Cancer Research Communications|July 12, 2024
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune MicroenvironmentsXiaojun Ma, David Lembersky, Elena S Kim, et al.
The American Journal of Gastroenterology|December 17, 1997
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver diseaseR Testa, S Caglieris, D Risso, et al.
Cancer Biology & Therapy|February 9, 2016
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alterationAlain C Borczuk, Jianming Pei, Robert N Taub, et al.
Human Molecular Genetics|May 19, 2021
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumorsMitchell Cheung, Yuwaraj Kadariya, Eleonora Sementino, et al.
Hepato-Gastroenterology|March 13, 1998
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosisR Testa, N Campo, S Caglieris, et al.
Genomics|October 3, 2000
Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressorA M Salicioni, M Xi, L A Vanderveer, et al.
Diabetes, Nutrition & Metabolism|June 1, 2001
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patientsA R Bonfigli, C Pieri, S Manfrini, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 26, 1999
Final height and endocrine function in thalassaemia intermediaV De Sanctis, A Tangerini, M R Testa, et al.
Pageof 59

Showing results (361-370 of 588) with videos related to

Sort By:
Pageof 59
Leukemia|November 1, 1992
The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemiaE J Lee, J Yang, R D Leavitt, et al.
Diabetes, Nutrition & Metabolism|April 27, 2000
A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patientsR Testa, A R Bonfigli, C Sirolla, et al.
Cancer Research Communications|July 12, 2024
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune MicroenvironmentsXiaojun Ma, David Lembersky, Elena S Kim, et al.
The American Journal of Gastroenterology|December 17, 1997
Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver diseaseR Testa, S Caglieris, D Risso, et al.
Cancer Biology & Therapy|February 9, 2016
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alterationAlain C Borczuk, Jianming Pei, Robert N Taub, et al.
Human Molecular Genetics|May 19, 2021
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumorsMitchell Cheung, Yuwaraj Kadariya, Eleonora Sementino, et al.
Hepato-Gastroenterology|March 13, 1998
Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosisR Testa, N Campo, S Caglieris, et al.
Genomics|October 3, 2000
Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressorA M Salicioni, M Xi, L A Vanderveer, et al.
Diabetes, Nutrition & Metabolism|June 1, 2001
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patientsA R Bonfigli, C Pieri, S Manfrini, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 26, 1999
Final height and endocrine function in thalassaemia intermediaV De Sanctis, A Tangerini, M R Testa, et al.
Pageof 59